Abstract
Hu, Jiang, et al. utilize patient adipose stem cell-derived adipocytes to reveal SNPs that modulate the effects of antidiabetic drugs by controlling genomic binding of PPARγ.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 299-308.e6 |
| Journal | Cell Stem Cell |
| Volume | 24 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 7 2019 |
| Externally published | Yes |
Keywords
- ABCA1
- adipocytes
- adipose stem cell
- antidiabetic drug
- drug response
- genetic variation
- PPARγ
- rosiglitazone
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology
Fingerprint
Dive into the research topics of 'Patient Adipose Stem Cell-Derived Adipocytes Reveal Genetic Variation that Predicts Antidiabetic Drug Response'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS